Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease

2d ago

GANX

PremiumCompany Announcements

Gain Therapeutics Welcomes New CFO Gene Mack

17d ago

GANX

PremiumPress Releases

Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer

18d ago

GANX

PremiumPress Releases

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer

25d ago

GANX

PremiumPress Releases

Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update

1M ago

GANX

PremiumPre-Earnings

GANX Earnings this Week: How Will it Perform?

1M ago

GANX

PremiumPress Releases

Gain Therapeutics to Present at Public Ventures Discovery Day

1M ago

GANX

More GANX News >

GANX News on the Web

2024-04-24

Gain Therapeutics Announces Positive Results from the Single Ascending Dose Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease

Yahoo Finance

Neutral

2024-04-23

Oppenheimer Remains a Buy on Gain Therapeutics (GANX)

TipRanks News

Bullish

2024-04-17

Here's Why Gain Therapeutics Could be Great Choice for a Bottom Fisher

Yahoo Finance

Neutral

2024-04-17

Here's Why Gain Therapeutics (GANX) Could be Great Choice for a Bottom Fisher

Zacks

Neutral

2024-04-10

Insiders are Piling into These 10 Healthcare Stocks in 2024

Yahoo Finance

Neutral

2024-04-10

Down -25.88% in 4 Weeks, Here's Why You Should You Buy the Dip in Gain Therapeutics

Yahoo Finance

Neutral

2024-04-10

Down -25.88% in 4 Weeks, Here's Why You Should You Buy the Dip in Gain Therapeutics (GANX)

Zacks

Neutral

2024-04-09

Alpine Immune Sciences Moves 10.4% Higher: Will This Strength Last?

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

GANX

Sector Average

Media Buzz

This Week2 articles

Weekly Average3.25 articles

News Sentiment

This Week100%

Sector Average59%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GANX’s Media Buzz Sentiment?

2 articles about GANX were published this week. In an average week, 3.25 articles are published.

What is GANX’s weekly average amount of articles?

In an average week, 3.25 articles about GANX are published.

What is GANX’s News Sentiment?

100% of articles about GANX were positive this week, compared to its sector average of 59%.

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

TAKTakeda Pharmaceutical Company

NBIXNeurocrine

AMEDAmedisys

MORFMorphic Holding

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing